- Pressure data is collected from the foot through a sensor-embedded insert worn in the shoe
- The system wirelessly sends information to a smartwatch that provides feedback from the feet
- When dangerous pressure levels have been detected the smartwatch alerts the user, so that behaviour can be changed and damage avoided
- Track progress with your personal Orpyx Connect Account. Use online charts to gain insight on how well you are preventing foot complications
The SurroSense Rx™ system was developed to address a common complication of diabetes, peripheral neuropathy, which affects upwards of 65% of diabetics over the course of their disease. The inability to sense and respond to sustained pressure can cause the development of debilitating complications including blisters and ulcers which can lead to surgical amputation. With proper intervention, neuropathic foot ulceration is a largely preventable complication.
The patent pending (US Publication #20120109013 and PCT WO/2012/055029) SurroSense Rx™ system is comprised of high-tech pressure-sensing inserts and smartwatch that provides direct feedback from the feet. The user is notified when they have exceeded recommended plantar pressure and are provided with offloading instructions so that behaviour can be changed and damage avoided. The system also tracks data over time through a web-based portal so the user can monitor their progress and improve metrics. Subscribe to our monthly e-newsletter to stay up to date on company milestones, product information and any relevant industry news.
Take the Next Step
The SurroSense Rx™ system is now available for purchase in select clinics podiatry, neuropathy and wound care clinics across the United States. Find the a clinic near you here, or email us at email@example.com for more information.